CLOV vs. DGNR, SKLZ, ALHC, TRUP, NEUE, BHG, NFH, UNH, ELV, and CI
Should you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Dragoneer Growth Opportunities (DGNR), Skillz (SKLZ), Alignment Healthcare (ALHC), Trupanion (TRUP), NeueHealth (NEUE), Bright Health Group (BHG), New Frontier Health (NFH), UnitedHealth Group (UNH), Elevance Health (ELV), and The Cigna Group (CI).
Clover Health Investments (NASDAQ:CLOV) and Dragoneer Growth Opportunities (NYSE:DGNR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking and earnings.
Dragoneer Growth Opportunities has lower revenue, but higher earnings than Clover Health Investments.
19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 65.5% of Dragoneer Growth Opportunities shares are owned by institutional investors. 22.3% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, Clover Health Investments had 9 more articles in the media than Dragoneer Growth Opportunities. MarketBeat recorded 9 mentions for Clover Health Investments and 0 mentions for Dragoneer Growth Opportunities. Clover Health Investments' average media sentiment score of 0.35 beat Dragoneer Growth Opportunities' score of 0.00 indicating that Clover Health Investments is being referred to more favorably in the media.
Clover Health Investments received 20 more outperform votes than Dragoneer Growth Opportunities when rated by MarketBeat users. However, 100.00% of users gave Dragoneer Growth Opportunities an outperform vote while only 39.62% of users gave Clover Health Investments an outperform vote.
Clover Health Investments presently has a consensus target price of $1.50, indicating a potential upside of 33.93%. Given Clover Health Investments' higher probable upside, analysts plainly believe Clover Health Investments is more favorable than Dragoneer Growth Opportunities.
Dragoneer Growth Opportunities has a net margin of 0.00% compared to Clover Health Investments' net margin of -8.63%. Dragoneer Growth Opportunities' return on equity of 0.00% beat Clover Health Investments' return on equity.
Summary
Clover Health Investments and Dragoneer Growth Opportunities tied by winning 6 of the 12 factors compared between the two stocks.
Get Clover Health Investments News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Clover Health Investments Competitors List
Related Companies and Tools
